Sometimes clinicians focus on things that we would not expect. Last week we had a little bit of information in our Homerun Slides about pramlintide. The response to these slides actually caught us by surprise and so this week we have dedicated all the slides to pramlintide and how best …

When traveling, “nearby” may mean closer than you think. A patient of mine, 35 years of age, with type 1 diabetes, boarded a plane. As recommended, she took her supplies, food, and treatment for a low with her in her carry-on bag. She had a window seat. She did not …

There has been a lot of press and discussion about using SGLT-2 inhibitors in type 1 diabetes due to the risk of DKA. Many of these articles focused on what happened to patients when they got DKA and whether it could be shown if the relationship was causal or causative. When …

Insulin Travel Adjustment GuideTABLE 2: Insulin Adjustment Traveling EAST Across Multiple Time Zones           Insulin Travel Adjustment Guide TABLE 2: Insulin Adjustment Traveling EAST Across Multiple Time Zones Day of Departure First Morning at Destination 10 Hours after Morning Dose Second Day at Destination Single dose …

Risk of hospitalization, early death doubled in type 2 patients… Cardiovascular complications have been linked to diabetes. However, according Dr. Timothy Davis from University of Western Australia, “there have been no detailed contemporary population-based studies of heart failure (HF) complicating type 2 diabetes.” In an effort to investigate predictors and …

Type 1 diabetes patients had a 30% higher risk of dying within six years after more than four hospitalizations for diabetic ketoacidosis…

A clinical trial to investigate whether repeated injections of the tuberculosis vaccine bacille Calmette-Guérin holds promise… The researchers announced the start of their phase 2 trial at the American Diabetes Association (ADA) 75th Scientific Sessions in Boston. Study author Denise Faustman, MD, director of the immunobiology laboratory at Massachusetts General …

No significant difference in incidence of infections, cancer, renal failure, or severe hypoglycemia… In patients with type 2 diabetes and cardiovascular disease, the use of sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used to lower HbA1c levels, is not associated with an increased risk of cardiovascular events, according to …

Combination of insulin, a GLP-1 receptor agonist and an SGLT-2 inhibitor effective, includes DKA risk.

Spouses or live-in partners of people newly diagnosed with diabetes twice as likely to develop diabetes…